This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Investors Heavily Search Axon Enterprise, Inc (AXON): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.
Axon Enterprise (AXON) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Axon Enterprise (AXON) closed at $382.57 in the latest trading session, marking a -0.83% move from the prior day.
Why Axon Enterprise (AXON) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Here's Why Axon Enterprise (AXON) Gained But Lagged the Market Today
by Zacks Equity Research
Axon Enterprise (AXON) reachead $361.71 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.
Is It Worth Investing in Axon (AXON) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Axon (AXON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Axon (AXON) Up 1.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Axon (AXON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.
Is SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XAR
Here's Why It is Appropriate to Retain AXON Stock Right Now
by Zacks Equity Research
AXON is set to benefit from solid momentum across its segments. However, increasing costs and expenses remain a concern.
Here's Why You Should Hold Axon Enterprise Stock in Your Portfolio
by Zacks Equity Research
AXON benefits from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may hurt its profitability.
Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Take the Zacks Approach to Beat the Markets: Vista Gold, TransMedics, Accenture in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Axon (AXON). This makes it worthwhile to examine what the stock has in store.
New to Investing? This 1 Industrial Products Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Here's Why You Should Invest in Axon Enterprise (AXON) Now
by Zacks Equity Research
Axon Enterprise (AXON) gains from strength across its businesses, acquired assets and strategic partnerships with other companies.
Take the Zacks Approach to Beat the Markets: New Jersey Resources, Axon, Coca-Cola in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Why This 1 Industrial Products Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
If You Invested $1000 in Axon Enterprise a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
ALLE vs. AXON: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALLE vs. AXON: Which Stock Is the Better Value Option?
Is Axon Enterprise (AXON) Stock Outpacing Its Industrial Products Peers This Year?
by Zacks Equity Research
Here is how Axon Enterprise (AXON) and Flowserve (FLS) have performed compared to their sector so far this year.
Axon Enterprise (AXON) Q2 Earnings Top Estimates, '24 View Raised
by Zacks Equity Research
Axon Enterprise's (AXON) Q2 revenues increase 34.6% year over year, driven by the impressive performance of its Software & Sensors and TASER segments.
Compared to Estimates, Axon (AXON) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Axon (AXON) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Axon Enterprise (AXON) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 13.21% and 5.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Axon (AXON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?